Skip to main content
. 2020 Nov 10;16(1):62–68. doi: 10.30699/ijp.2020.117676.2283

Table 3.

The frequency of MTRR c.66A>G polymorphism in breast cancer patients compared to control group

MTRR
c.66A>G
Patients
n= 99
n (%)
Controls
n=141
n (%)
χ2, P
Genotype
AA 18 (18.2) 15 (10.6) -
AG 65 (65.7) 107 (75.9) 2.88, 0.09
GG 16 (16.1) 19 (13.5) 0.36, 0.54
Allele
A 101 (51) 137 (48.6) 0.19, 0.65
G 97 (49) 145 (51.4)

Overall χ2= 3.28, P-value=0.19